Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Urwin, Patrick ; Thanigaikumar, Kumar ; Ironside, James W. ; Molesworth, Anna ; Knight, Richard S. ; Hewitt, Patricia E. ; Llewelyn, Charlotte ; Mackenzie, Jan ; Will, Robert G.
• Description:
  Sporadic Creutzfeldt-Jakob disease (sCJD) has not been previously reported in patients with clotting disorders treated with fractionated plasma products. We report 2 cases of sCJD identified in the United Kingdom in patients with a history of extended treatment for clotting disorders; 1 patient had hemophilia B and the other von Willebrand disease. Both patients had been informed previously that they were at increased risk for variant CJD because of past treatment with fractionated plasma products sourced in the United Kingdom. However, both cases had clinical and investigative features suggestive of sCJD. This diagnosis was confirmed in both cases on neuropathologic and biochemical analysis of the brain. A causal link between the treatment with plasma products and the development of sCJD has not been established, and the occurrence of these cases may simply reflect a chance event in the context of systematic surveillance for CJD in large populations.
• Subjects:
  Brain Creutzfeldt-Jakob Syndrome Female Humans Middle Aged
• Source:
  Emerg Infect Dis. 23(6):893-897.
• Pubmed ID:
  28516863
• Pubmed Central ID:
  PMC5443442
• Document Type:
  Journal Article
• Place as Subject:
  United Kingdom
• Volume:
  23
• Issue:
  6
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:98b94259e91fa124e0735846f44780d53919ef62f1bd557ecba3947c2d72a05c
• Download URL:
  https://stacks.cdc.gov/view/cdc/45983/cdc_45983_DS1.pdf
• File Type:
  [PDF - 1.27 MB ]